Showing results (381-390 of 404) with videos related to

Sort By:
Pageof 41
Pilot and Feasibility Studies|April 22, 2022
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 TrialNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
European Heart Journal|November 4, 2022
Serial troponin-T and long-term outcomes in suspected acute coronary syndromeManan Pareek, Kristian H Kragholm, Anna Meta Dyrvig Kristensen, et al.
Respiratory Investigation|November 2, 2025
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trialLisa Steen Duus, Niklas Dyrby Johansen, Daniel Modin, et al.
Clinical Epidemiology|November 9, 2016
The Danish Cardiac Rehabilitation DatabaseAnn-Dorthe Zwisler, Henriette Knold Rossau, Anne Nakano, et al.
Human Vaccines & Immunotherapeutics|January 8, 2026
A Bayesian re-analysis of the DANFLU-1 trialDaniel Modin, Niklas Dyrby Johansen, Anders Granholm, et al.
Circulation. Cardiovascular Quality and Outcomes|August 31, 2024
Relative Effectiveness of High-Dose Versus Standard-Dose Quadrivalent Influenza Vaccine in Older Adults With Cardiovascular Disease: A Prespecified Analysis of the DANFLU-1 Randomized Clinical TrialJacob Christensen, Niklas Dyrby Johansen, Daniel Modin, et al.
Plos One|February 7, 2019
Association of genetic variants previously implicated in coronary artery disease with age at onset of coronary artery disease requiring revascularizationsCharlotte Andersson, Maria Lukács Krogager, Regitze Kuhr Skals, et al.
The Journal of Infection|September 20, 2024
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trialJacob Christensen, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
Diabetes, Obesity & Metabolism|April 8, 2024
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Daniel Modin, et al.
American Heart Journal|August 1, 2025
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trialNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Pageof 41